立萬利創新股份有限公司 (3054) 2026Q2 法說會簡報
Company Overview
- 公司名稱: 立萬利創新股份有限公司 (LIWANLI Innovation Co., Ltd.)
- 股票代碼 (Stock Code): 3054
- 董事長 (Chairman): 陳立青 (Jason Chen)
- 公司成立 (Date of Establishment): 1991年6月 (June, 1991)
- 股票上市 (Date of listing on TWSE): 2002年11月 (November, 2002)
- 實收資本額 (Paid-in Capital): 新臺幣8.07億元 (NTD 807 Million)
- 營業項目 (Business Scope):
- (1) 電子產品貿易銷售 (Trading and sales of electronic products)
- (2) 保健食品相關產品的開發與銷售 (Development and sales of health supplement products)
Financial Highlights
合併營收 (Revenue of Consolidation)
- 2024年度: NT$ 99,156 thousand
- 2025年度: NT$ 125,540 thousand
- 2026年第二季: NT$ 339,319 thousand
合併營業毛利 (Gross Profit of Consolidation)
- 2024年度: NT$ 20,833 thousand
- 2025年度: NT$ 39,110 thousand
- 2026年第二季: NT$ 182,898 thousand
合併營業淨利(損) (Operation Income/Loss of Consolidation)
- 2024年度: (NT$ 37,346) thousand
- 2025年度: (NT$ 70,829) thousand
- 2026年第二季: NT$ 128,978 thousand
合併本期淨利(損) (Net Income/Loss of Consolidation)
- 2024年度: (NT$ 32,074) thousand
- 2025年度: NT$ 158,146 thousand
- 2026年第二季: NT$ 233,983 thousand
財務結構 (Financial Analysis - Consolidated)
- 流動比率 (Current Ratio):
- 2025/06/30: 1330%
- 2025/12/31: 705%
- 2026/06/30: 431%
- 負債比率 (Debt Ratio):
- 2025/06/30: 4.23%
- 2025/12/31: 7.49%
- 2026/06/30: 11.47%
Business Segments
近年主要產品項目及營業比重 (Main Products and Revenue Mix)
| 產品別 (Category) | 主要產品項目 (Main Products) | 2024 | 2025 | 2026 Q2 |
|---|---|---|---|---|
| 儲存裝置 (Storage products) | 包括DRAM等相關記憶體產品 (Including DRAM products). | 60.91% | 64.93% | 94.63% |
| 其他 (others) | 保健食品及其他產品 (Health supplements and other products). | 39.09% | 35.07% | 5.37% |
| 合計 | 100% | 100% | 100% |
Products & Technologies
生技類產品介紹 (Biotechnology products)
威客維專科系列 (VIGOWAY Specialty Series)
- 威舒益PLUS酵母益生菌粉包 (ibSium-HST Probiotic)
- 威舒暢PLUS+益菌酵素粉包 (Probiotic Enzyme PLUS+)
- 威而潤PLUS智利酒果粉包 (MaquiBright Lutein)
- 威護伸PLUS 接骨木莓粉包 (Black Elderberry)
- 威護節軟膠囊 (Shea Butter Oil with Patented Type II Collagen Softgels)
- 威鈣素微泡口嚼錠 (Osteocalcin Fizz Chew Essence)
- 易舒眠極靜GABA深層緩釋膠囊 (E-Soothing GABA Deep)
威客維機能系列 (VIGOWAY Functional Series)
- 黃金虫草子實體膠囊 (Cordyceps Militaris Capsule)
- NAD+青春賦能粉包 (New Anti-aging Desire+)
- 威攝士膠囊 (Pro-Active Nutrients)
威客維三麗鷗聯名/兒童系列 (VIGOWAY Sanrio Co-branded/Kids Series)
- 威敏暢酵素益菌粉包 (Kids Probiotic Enzyme Powder)
- 滴D優滴液 (DHA D3 drops)
- 護晶明PLUS咀嚼錠 (Extra Bright Bilberry Plus Tablets)
威客維美妍系列 (VIGOWAY Beauty Series)
- 醇萃活鐵補精 (GoyoungFe Essence)
- 白藜蘆醇美妍精華飲 (Red Grape Extract contains Resveratrol)
滴滴鮮養生系列 (DDDrops Health Series)
- 滴滴鮮滴雞精 (DDDrops Essence of Chicken)
- 滴滴鮮彈力膠原滴雞精 (DDDrops Essence of Chicken With Beauty Collagen)
- 滴一鮮仁蔘精華飲 (DEDrops Ginseng Tonic Drink)
電商新品牌 森一 (E-commerce New Brand SenOne)
- 72歐洲專利黑接骨木莓+C (SenOne 72 Elderberry+C)
- 90蔬果好孅 專利代謝酵素 (Greenzyme Fiber 90)
- 高濃縮蔓越莓益生菌植物膠囊 (SenOne Cranberry Probiotic Complex)
- 強化型金盞花葉黃素植物膠囊 (SenOne Marigold Lutein Complex)
代理品牌 NYO3 (Agency Brand NYO3)
- NYO3 南極磷蝦油 (NYO3 Antarctic Krill Oil Soft Gel Capsules)
Clients & Markets
銷售通路 (Sales Channels)
- 實體通路 (Physical Retail Channels):
- 康是美藥妝店 (Cosmed)
- 大樹連鎖藥局 (Great Tree Pharmacy)
- 躍獅連鎖藥局 (Yes Chain Pharmacy)
- 美康健保藥局 (Mei Kang Health Insurance Pharmacy) (雙北桃園區域連鎖)
- 全球連鎖 (Global Chain Pharmacy) (桃園區域)
- 唯新婦嬰藥妝 (Weixin Mother & Baby Pharmacy)
- 電商平台 (E-commerce Platforms):
- Vigoway 官方網站 (Vigoway Official Website)
- Find Best 購物網站 (Find Best Shopping Website)
- 蝦皮商城 Vigoway x SenOne (Shopee Mall Vigoway x SenOne)
- momo購物網 (momo Shopping Network)
- ETMall 東森購物 (ETMall Eastern Shopping)
- PChome
- 博客來 (Books.com.tw)
Outlook & Strategy
公司展望 (Business Outlook)
生技保健事業:品牌與通路拓展 (Biotech & Health: Brand & Channel Expansion)
- 產品研發 (Product R&D): 持續推進新品開發,維持產品更新節奏 (Developing new products on a quarterly basis to enrich our product portfolio).
- 專業合作 (Professional Collaboration): 與專科醫師合作,強化品牌專業形象 (Collaborating with medical specialists to strengthen brand credibility).
- 精準行銷 (Precision Marketing): 優化電商與社群行銷 (Optimizing e-commerce and social media marketing).
- 業務與市場布局 (Business & Market Strategy): 拓展客戶與通路,評估海內外OEM/ODM合作機會 (Expanding customer and distribution networks while exploring domestic and overseas OEM/ODM opportunities).
電子貿易事業:穩健與靈活 (Electronics Trading: Stability & Agility)
- 靈活營運 (Agile Operations): 掌握市場供需與價格變化,維持穩健營運 (Monitoring market supply, demand and price trends to maintain operational stability).
Additional Data
策略里程碑 (Strategy Milestones)
- 1991-2014 | 基礎奠定 (Establishment & Foundation):
- 1991年6月: 設立「萬國電腦股份有限公司」 (Established as Carry Computer Engineering Co., Ltd.).
- 深耕電子產品研發、製造與貿易業務 (Focused on the R&D, manufacturing, and trading of electronic products).
- 2002年11月: 於台灣證券交易所掛牌上市 (3054) (Listed on the Taiwan Stock Exchange (TWSE: 3054) in November 2002).
- 2015-2020 | 策略轉型 (Strategic Transformation):
- 2015年7月: 更名為「立萬利創新股份有限公司」,啟動組織調整 (Renamed LIWANLI Innovation Co., Ltd. and initiated organizational restructuring in July 2015).
- 2015年11月: 調整營運結構,逐步退出低毛利製造業務 (Restructured operations and gradually phased out low-margin manufacturing activities in November 2015).
- 2017年起: 拓展生技保健食品業務 (Expanded into the biotechnology and health supplement business starting in 2017).
- 2021-迄今 | 多元發展 (Business Diversification):
- 電子產品與生技保健事業並行發展 (Electronics and biotech & health businesses operating in parallel).
- 生技保健產品獲得品質獎項及認證 (Monde Selection、SNQ) (Health supplement products recognized through quality awards and certifications, including Monde Selection and SNQ).
- Monde Selection Awards: GOLD (2026, 2025, 2024, 2023), SILVER (2022), GRAND GOLD (2021) for Diet & Health Awards.
- 2024第一屆醫療科技團體獎 (Medical Technology Team Award).
核心優勢與定位 (Core Strengths & Strategic Positioning)
- 永續經營核心 (Sustainable Core Values): 以「創新、價值、服務、品質」為根基,持續優化事業組合與營運結構 (Rooted in "Innovation, Value, Service, and Quality," with a focus on optimizing our business portfolio and operations).
- 雙軌營運模式 (Dual-Business Model): 結合電子貿易與生技保健事業,提升整體營運穩定性 (Operating electronics and health supplement businesses in parallel to enhance operational stability).
- 卓越品質保證 (Quality Excellence): 多項產品獲得 Monde Selection 及 SNQ 等品質獎項與認證,持續強化產品品質 (Products recognized by Monde Selection and SNQ, reflecting our commitment to quality).
- 提升股東價值 (Enhanced Shareholder Value): 兼具電子貿易與保健品銷售,致力於提升營運韌性與長期發展動能 (Enhancing operational resilience and long-term growth).
簡明合併綜合損益表 (Condensed Statement of Income-Consolidated)
單位:新台幣仟元;% (Unit: NT$ thousand;%)
| 項目 (Item) | 2026/01/01~2026/06/30 Amount (%) | 2025/01/01~2025/06/30 Amount (%) |
|---|---|---|
| 營業收入 (Net Revenue) | 339,319 (100) | 50,191 (100) |
| 營業成本 (Cost of Revenue) | (156,421) (46) | (35,640) (71) |
| 營業毛利 (Gross Profit) | 182,898 (54) | 14,551 (29) |
| 營業費用 (Operating Expense) | (53,920) (16) | (30,933) (62) |
| 營業淨利(損) (Operating Profit/Loss) | 128,978 (38) | (16,382) (33) |
| 營業外收入及利益 (Non-operating Income and Expense) | 125,660 (37) | 16,209 (32) |
| 稅前淨利 (Income Before Income Tax) | 254,638 (75) | (173) (0) |
| 所得稅費用 (Income Tax Expense) | (20,655) (6) | 570 (0) |
| 本期淨利 (Net Income) | 233,983 (69) | 397 (1) |
| 基本每股盈餘(損失)(元) (Basic EPS(NT $ dollar)) | 2.90 | 0.00 |
簡明合併資產負債表 (Condensed Balance Sheet-Consolidated)
單位:新台幣仟元;% (Unit: NT$ thousand;%)
| 項目 (Item) | 2026/06/30 Amount (%) | 2025/12/31 Amount (%) | 2025/06/30 Amount (%) |
|---|---|---|---|
| 流動資產 (Current Assets) | 830,851 (48) | 559,815 (49) | 374,618 (48) |
| 透過其他綜合損益按公允價值衡量之金融資產-非流動 (Financial assets at fair value through other comprehensive income) | 581,138 (33) | 255,374 (22) | 72,632 (9) |
| 不動產、廠房及設備 (Property, plant and equipment) | 10,588 (1) | 11,582 (1) | 12,036 (2) |
| 使用權資產 (Right-of-use assets) | 1,011 (0) | 1,228 (0) | 118 (0) |
| 投資性不動產淨額 (Investment property) | 293,117 (17) | 294,491 (26) | 295,866 (38) |
| 其他非流動資產 (Others noncurrent assets) | 20,579 (1) | 19,176 (2) | 20,881 (3) |
| 資產總額 (Total of Assets) | 1,737,284 (100) | 1,141,666 (100) | 776,151 (100) |
| 流動負債 (Current liabilities) | 192,846 (11) | 79,441 (7) | 28,157 (4) |
| 非流動負債 (Noncurrent liabilities) | 6,397 (0) | 6,101 (0) | 4,699 (0) |
| 負債總額 (Total of Liabilities) | 199,243 (11) | 85,542 (7) | 32,856 (4) |
| 股本 (Capital stock) | 806,510 (46) | 806,510 (71) | 806,510 (104) |
| 資本公積 (Capital surplus) | - (-) | - (-) | - (-) |
| 保留盈餘 (Retained earnings) | 320,373 (19) | 150,910 (13) | 25,377 (3) |
| 其他權益 (Other equity) | 411,158 (24) | 98,704 (9) | (88,592) (11) |
| 股東權益總額 (Total of Equity) | 1,538,041 (89) | 1,056,124 (93) | 743,295 (96) |
| 負債及股東權益總額 (Total of Liability and Equity) | 1,737,284 (100) | 1,141,666 (100) | 776,151 (100) |
Disclaimers
- 本公司並未發布財務預測。本簡報所提供之業務、財務及問答相關資訊,若涉及對未來經營及產業發展之看法,可能與未來實際結果有所差異。相關差異可能受到市場需求、價格波動、競爭情勢、全球經濟環境、匯率變動、上下游供應鏈及其他本公司無法控制之風險因素影響。
- LIWANLI Innovation Co., Ltd. does not issue financial forecasts. However, statements regarding the Company's business, financial condition, and Q&A in this presentation, particularly those relating to future operations and industry development, may differ from actual future results. Such differences may arise from changes in market demand, price fluctuations, competitive conditions, global economic conditions, exchange rate movements, supply chain developments, and other risks or factors beyond the Company's control.
- 本簡報係依據本公司自各項來源取得之資訊編製。未來如有任何變更或調整,請以公開資訊觀測站 (MOPS) 所公告之資訊為準。
- This presentation is based on information obtained from various sources that the Company believes to be reliable. In the event of any future changes or adjustments, please refer to the information disclosed on the Market Observation Post System (MOPS).